La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Putamen »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Purines < Putamen < Putrescine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000186 (2016) Gaetano Barbagallo ; Maria Sierra-Pe A ; Federico Nemmi ; Anne Pavy-Le Traon ; Wassilios G. Meissner ; Olivier Rascol ; Patrice PéranMultimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
000441 (2015) Federico Nemmi ; Umberto Sabatini ; Olivier Rascol ; Patrice PéranParkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis.
000591 (2014) Stéphane Palfi ; Jean Marc Gurruchaga ; G Scott Ralph ; Helene Lepetit ; Sonia Lavisse ; Philip C. Buttery ; Colin Watts ; James Miskin ; Michelle Kelleher ; Sarah Deeley ; Hirokazu Iwamuro ; Jean Pascal Lefaucheur ; Claire Thiriez ; Gilles Fenelon ; Cherry Lucas ; Pierre Brugières ; Inanna Gabriel ; Kou Abhay ; Xavier Drouot ; Naoki Tani ; Aurelie Kas ; Bijan Ghaleh ; Philippe Le Corvoisier ; Patrice Dolphin ; David P. Breen ; Sarah Mason ; Natalie Valle Guzman ; Nicholas D. Mazarakis ; Pippa A. Radcliffe ; Richard Harrop ; Susan M. Kingsman ; Olivier Rascol ; Stuart Naylor ; Roger A. Barker ; Philippe Hantraye ; Philippe Remy ; Pierre Cesaro ; Kyriacos A. MitrophanousLong-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
000618 (2014) Mathieu Bourdenx ; Anna Nilsson ; Henrik Wadensten ; Maria F Lth ; Qin Li ; Alan R. Crossman ; Per E. Andrén ; Erwan BezardAbnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.
000621 (2014) M. Anheim[Triple-gene therapy in Parkinson disease (ProSavin): toward a putaminal dopamine factory?].
000803 (2013) Miguel Ulla ; Jean Marie Bonny ; Lemlih Ouchchane ; Isabelle Rieu ; Beatrice Claise ; Franck DurifIs R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.
001003 (2004) Jean-Christophe Corvol ; Marie-Paule Muriel ; Emmanuel Valjent ; Jean Féger ; Naïma Hanoun ; Jean-Antoine Girault ; Etienne C. Hirsch ; Denis HervéPersistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.
001239 (2001) T. Poyot ; F. Condé ; M C Grégoire ; V. Frouin ; C. Coulon ; C. Fuseau ; F. Hinnen ; F. Dollé ; P. Hantraye ; M. BottlaenderAnatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
001394 (1999) E. Broussolle ; C. Dentresangle ; P. Landais ; L. Garcia-Larrea ; P. Pollak ; B. Croisile ; O. Hibert ; F. Bonnefoi ; G. Galy ; J C Froment ; D. ComarThe relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
001430 (1999) M. Levivier[Intracerebral grafts in Parkinson disease. Current experiences and perspectives].
001521 (1997) S. Palfi ; D. Riche ; E. Brouillet ; M C Guyot ; V. Mary ; F. Wahl ; M. Peschanski ; J M Stutzmann ; P. HantrayeRiluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
001554 (1997) C. Gargalidis-Moudanos ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. PariniI2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
001557 (1997) M. Levivier ; S. Dethy ; F. Rodesch ; M. Peschanski ; A. Vandesteene ; P. David ; D. Wikler ; S. Goldman ; T. Claes ; F. Biver ; C. Liesnard ; M. Goldman ; J. Hildebrand ; J. BrotchiIntracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
001567 (1996) F. Picard ; A. De Saint-Martin ; E. Salmon ; E. Hirsch ; C. MarescauxPostencephalitic stereotyped involuntary movements responsive to L-Dopa.
001612 (1995) R. Levy ; M. Vila ; M T Herrero ; B. Faucheux ; Y. Agid ; E C HirschStriatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease.
001626 (1995) P. Ryvlin ; E. Broussolle ; H. Piollet ; F. Viallet ; Y. Khalfallah ; G. ChazotMagnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease.
001648 (1995) R M Marié ; L. Barré ; P. Rioux ; P. Allain ; B. Lechevalier ; J C BaronPET imaging of neocortical monoaminergic terminals in Parkinson's disease.
001860 (1988) L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Y. AgidD1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Putamen" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Putamen" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Putamen
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024